Stacy L. Cooper

Stacy L. Cooper

Pediatric Hematology Oncology | Pediatrics
1800 Orleans Street, Bloomberg 11N
Bloomberg 11N
Baltimore, MD 21287

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications

The Future of Pediatric Hematology-Oncology Fellowship Training: Reflections on the American Board of Pediatrics Training Model.

The Future of Pediatric Hematology-Oncology Fellowship Training: Reflections on the American Board of Pediatrics Training Model.

Journal: Pediatric blood & cancer
Published: June 04, 2026

Protecting Children This World Health Day: The Case for Early Childhood Cancer Detection Through Primary Health Care Strengthening in Vietnam.

Protecting Children This World Health Day: The Case for Early Childhood Cancer Detection Through Primary Health Care Strengthening in Vietnam.

Journal: Pediatric blood & cancer
Published: March 20, 2026

Population Pharmacokinetics of Bosutinib in Children with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Based on a Phase I Dose-Finding Trial (ITCC-054/COG AAML1921) and Pediatric Recommended Phase II Dosage Evaluation.

Population Pharmacokinetics of Bosutinib in Children with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Based on a Phase I Dose-Finding Trial (ITCC-054/COG AAML1921) and Pediatric Recommended Phase II Dosage Evaluation.

Journal: Clinical pharmacokinetics
Published: February 05, 2026

Reduced-intensity reinduction for children and young persons with relapsed acute lymphoblastic leukemia.

Reduced-intensity reinduction for children and young persons with relapsed acute lymphoblastic leukemia.

Journal: Leukemia
Published: October 06, 2025

State Medigap Policies and Disenrollment From Medicare Advantage Among Beneficiaries With Cancer.

State Medigap Policies and Disenrollment From Medicare Advantage Among Beneficiaries With Cancer.

Journal: JCO oncology practice
Published: July 07, 2025

Visualizing Multi-Step Decision-Making at a Glance: Pairing Choose Your Own Adventure Style Simulated Cases with a Novel Mapping Framework.

Visualizing Multi-Step Decision-Making at a Glance: Pairing Choose Your Own Adventure Style Simulated Cases with a Novel Mapping Framework.

Journal: Medical science educator
Published: June 02, 2025

Liberalizing hospital proximity requirements for children/young adults with low-burden B-ALL receiving tisagenlecleucel.

Liberalizing hospital proximity requirements for children/young adults with low-burden B-ALL receiving tisagenlecleucel.

Journal: Blood advances
Published: April 29, 2025

Pediatric Acute Lymphoblastic Leukemia, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.

Pediatric Acute Lymphoblastic Leukemia, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: February 12, 2025

Real-world outcomes for young adult patients receiving CD19 CAR T-cell therapy.

Real-world outcomes for young adult patients receiving CD19 CAR T-cell therapy.

Journal: Blood advances
Published: September 20, 2024

Low-risk relapsed acute lymphoblastic leukemia in children and young adults: what have we learnt and what's next?

Low-risk relapsed acute lymphoblastic leukemia in children and young adults: what have we learnt and what's next?

Journal: Leukemia & lymphoma
Published: June 11, 2024

Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921.

Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 30, 2023

Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns.

Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns.

Journal: EClinicalMedicine
Published: March 13, 2023
Showing 1-12 of 42

Last Updated: 09/26/2026